Cargando…

P2Y12 platelet inhibition in clinical practice

Platelet adhesion, activation and aggregation play a pivotal role in atherothrombosis. Intracoronary atherothrombosis is the most common cause of the development of acute coronary syndrome (ACS), and plays a central role in complications occurring around percutaneous coronary intervention (PCI) incl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Damman, Peter, Woudstra, Pier, Kuijt, Wichert J., de Winter, Robbert J., James, Stefan K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3269569/ https://www.ncbi.nlm.nih.gov/pubmed/22183178 http://dx.doi.org/10.1007/s11239-011-0667-5

Ejemplares similares

Admission Lipoprotein-Associated Phospholipase A(2) Activity Is Not Associated with Long-Term Clinical Outcomes after ST-Segment Elevation Myocardial Infarction
por: Woudstra, Pier, et al.
Publicado: (2014)

Gender difference in the prognostic value of estimated glomerular filtration rate at admission in ST-segment elevation myocardial infarction: a prospective cohort study
por: Damman, Peter, et al.
Publicado: (2012)

The Ratio of ADP- to TRAP-Induced Platelet Aggregation Quantifies P2Y(12)-Dependent Platelet Inhibition Independently of the Platelet Count
por: Olivier, Christoph B., et al.
Publicado: (2016)

Antipsychotic Drugs Inhibit Platelet Aggregation via P2Y(1) and P2Y(12) Receptors
por: Wu, Chang-Chieh, et al.
Publicado: (2016)

The P2Y(12) Antagonists, 2MeSAMP and Cangrelor, Inhibit Platelet Activation through P2Y(12)/G(i)-Dependent Mechanism
por: Xiang, Binggang, et al.
Publicado: (2012)

Uridine Triphosphate Thio Analogues Inhibit Platelet P2Y(12) Receptor and Aggregation
por: Gündüz, Dursun, et al.
Publicado: (2017)

Comparison of three common whole blood platelet function tests for in vitro P2Y12 induced platelet inhibition
por: Dias, Joao D., et al.
Publicado: (2019)

Circulating MicroRNA Levels Indicate Platelet and Leukocyte Activation in Endotoxemia Despite Platelet P2Y(12) Inhibition
por: Braza-Boïls, Aitana, et al.
Publicado: (2020)

Gene sequence variations of the platelet P2Y12 receptor are associated with coronary artery disease
por: Cavallari, Ugo, et al.
Publicado: (2007)

P2Y(12) Inhibition in Murine Myocarditis Results in Reduced Platelet Infiltration and Preserved Ejection Fraction
por: Schmidt, Sarah Nasreen, et al.
Publicado: (2021)

GRK2 regulates ADP signaling in platelets via P2Y(1) and P2Y(12)
por: Zhao, Xuefei, et al.
Publicado: (2022)

P2Y12 antagonist ticagrelor inhibits the release of procoagulant extracellular vesicles from activated platelets
por: Gasecka, Aleksandra, et al.
Publicado: (2020)

P2Y(12) receptor blockade synergizes strongly with nitric oxide and prostacyclin to inhibit platelet activation
por: Chan, Melissa V., et al.
Publicado: (2016)

Aspirin and P2Y(12) inhibition attenuate platelet-induced ovarian cancer cell invasion
por: Cooke, Niamh M., et al.
Publicado: (2015)

P2Y12 blocker monotherapy after percutaneous coronary intervention
por: Verheugt, F. W. A., et al.
Publicado: (2021)

DT‐678 inhibits platelet activation with lower tendency for bleeding compared to existing P2Y(12) antagonists
por: Lauver, Dale A., et al.
Publicado: (2019)

Gender-based differences in platelet function and platelet reactivity to P2Y(12) inhibitors
por: Ranucci, Marco, et al.
Publicado: (2019)

Platelet P2Y12 Is Involved in Murine Pulmonary Metastasis
por: Wang, Yanhua, et al.
Publicado: (2013)

Transcatheter closure of an iatrogenic aorta-right ventricular fistula after transfemoral aortic valve implantation
por: Damman, Peter, et al.
Publicado: (2017)

Cell Surface Platelet Tissue Factor Expression: Regulation by P2Y(12) and Link to Residual Platelet Reactivity
por: Brambilla, Marta, et al.
Publicado: (2023)

P2Y(12) Platelet Receptors: Importance in Percutaneous Coronary Intervention
por: Falcão, Felipe Jose de Andrade, et al.
Publicado: (2013)

Inhibitory Effect of Flavonolignans on the P2Y12 Pathway in Blood Platelets
por: Bijak, Michal, et al.
Publicado: (2018)

Platelet Reactivity And Circulating Platelet-Derived Microvesicles Are Differently Affected By P2Y(12) Receptor Antagonists
por: Chyrchel, Bernadeta, et al.
Publicado: (2019)

Residual platelet ADP reactivity after clopidogrel treatment is dependent on activation of both the unblocked P2Y(1) and the P2Y(12) receptor and is correlated with protein expression of P2Y(12)
por: Braun, Oscar Ö, et al.
Publicado: (2006)

D121 Located within the DRY Motif of P2Y12 Is Essential for P2Y12-Mediated Platelet Function
por: Dangelmaier, Carol, et al.
Publicado: (2022)

GLS-409, an Antagonist of Both P2Y(1) and P2Y(12), Potently Inhibits Canine Coronary Artery Thrombosis and Reversibly Inhibits Human Platelet Activation
por: Smolensky Koganov, Elena, et al.
Publicado: (2018)

Optimal Medical Therapy Prescription in Patients with Acute Coronary Syndrome in the Netherlands: A Multicenter Pilot Registry
por: Hoedemaker, Niels P. G., et al.
Publicado: (2020)

Selective and rapid monitoring of dual platelet inhibition by aspirin and P2Y(12 )antagonists by using multiple electrode aggregometry
por: Penz, Sandra M, et al.
Publicado: (2010)

Platelet P2Y (12) Receptor Deletion or Pharmacological Inhibition does not Protect Mice from Sepsis or Septic Shock
por: Rabouel, Yannick, et al.
Publicado: (2021)

When Less Becomes More: Insights on the Pharmacodynamic Effects of Aspirin Withdrawal in Patients With Potent Platelet P2Y(12) Inhibition Induced by Ticagrelor
por: Capodanno, Davide, et al.
Publicado: (2020)

Publisher Correction: GLS-409, an Antagonist of Both P2Y(1) and P2Y(12), Potently Inhibits Canine Coronary Artery Thrombosis and Reversibly Inhibits Human Platelet Activation
por: Smolensky Koganov, Elena, et al.
Publicado: (2018)

P2Y(12) Receptor Blockade Augments Glycoprotein IIb‐IIIa Antagonist Inhibition of Platelet Activation, Aggregation, and Procoagulant Activity
por: Berny‐Lang, Michelle A., et al.
Publicado: (2013)

Assessment of P2Y(12) Inhibition by Clopidogrel in Feline Platelets Using Flow Cytometry Quantification of Vasodilator-Stimulated Phosphoprotein Phosphorylation
por: Li, Ronald H. L., et al.
Publicado: (2020)

Stabilizing Role of Platelet P2Y(12) Receptors in Shear-Dependent Thrombus Formation on Ruptured Plaques
por: Nergiz-Unal, Reyhan, et al.
Publicado: (2010)

Glycoprotein IIb/IIIa and P2Y(12) Induction by Oligochitosan Accelerates Platelet Aggregation
por: Periayah, Mercy Halleluyah, et al.
Publicado: (2014)

The P2Y12 Receptor Antagonist Selatogrel Dissolves Preformed Platelet Thrombi In Vivo
por: Crescence, Lydie, et al.
Publicado: (2021)

Comparison of the effects of the GPIIb-IIIa antagonist Zalunfiban and the P2Y12 antagonist Selatogrel on Platelet Aggregation
por: Curry, Benjamin J., et al.
Publicado: (2023)

Adenosine Receptor Agonists Increase the Inhibition of Platelet Function by P2Y(12) Antagonists in a cAMP- and Calcium-Dependent Manner
por: Wolska, Nina, et al.
Publicado: (2020)

Head-to-Head Comparison of Consensus-Recommended Platelet Function Tests to Assess P2Y(12) Inhibition—Insights for Multi-Center Trials
por: Bélanger, Jean-Christophe, et al.
Publicado: (2020)

12-hydroxyeicosatetraenoic acid is associated with variability in aspirin-induced platelet inhibition
por: Maskrey, Benjamin H, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7jdllgp5k41u4nc9gosdigbb68